Martin Shkreli resigns as Turing CEO day after his arrest

TRENTON, N.J. -- The pharmaceutical executive reviled for price-gouging resigned Friday as head of the drugmaker Turing Pharmaceuticals, a day after being arrested on charges of securities fraud related to a company he previously ran.

See Full Article

Martin Shkreli, whose arrest delighted countless people appalled by his unapologetic stance after hiking the price of a life-saving drug by 5,000 per cent, is being replaced on an interim basis by Ron Tilles, according to a statement issued Friday by Turing, which is privately held.

Tilles has been chairman of Turing's board of directors since the company was founded late last year. Turing said that Tilles will continue to hold the board chairman position as well. He has worked at numerous private equity and venture capital firms in the pharmaceutical and medical device industries over the last two decades.

Shkreli, a 32-year-old former hedge fund manager, has become the "most hated man in America," according to some headline writers, for jacking up the price of Daraprim, the only approved drug for a life-saving parasitic infection called toxoplasmosis, from $13.50 to $750 per pill. He did so shortly after Turing acquired rights to sell the pill in the U.S., paying another company $55 million for it.

On Thursday, federal prosecutors said that between 2009 and 2014, Shkreli lost some of his hedge fund investors' money through bad trades, then looted Retrophin, a pharmaceutical company where he was CEO, for $11 million to pay back his disgruntled clients.

Shkreli, a flagrant self-promoter who recently said he should have hiked the price of Daraprim even more, was paraded in handcuffs by the FBI after his arrest. Photos of him, wearing a grey hoodie as he was escorted by authorities, spread on the Internet like wildfire, generating social media posts celebrating his apparent fall. The news -- unrelated to his actions at Turing -- delighted patients, advocacy groups and average Joes who found his price-gouging despicable.

Shkreli pleaded not guilty to charges of securities fraud and conspiracy, which carry a sentence of up to 20 years in prison if he's convicted. He was released on $5 million bail.

Turing, which has offices in New York and Zug, Switzerland, said Tilles has worked with several securities firms, starting with Merrill Lynch in 1985.

In the company's statement, Tilles said he's excited by the chance to guide Turing and that it's "committed to ensuring that all patients have ready and affordable access to Daraprim" and a second drug, Vecamyl, a pill for treating high blood pressure.

Tilles also thanked Shkreli "for helping us build Turing Pharmaceuticals into the dynamic research-focused company it is today," a reference to Shkreli's after-the-fact claim that he needed to raise Daraprim's price so much to fund research on other drugs.

Shkreli recently became the CEO of a second company, KaloBios Pharmaceuticals, Inc., based in South San Francisco, California. There's no word yet on whether he'll remain at the helm there.



Advertisements

Latest Economic News

  • Who killed Sears question sparks bitter blame game among top players

    Economic CBC News
    Sears Canada may be over, but the mudslinging over who brought it down has just begun. Majority shareholder Eddie Lampert fired the latest shot in a blog on Sunday. If Sears Canada had adopted a less risky reinvention strategy, it could have avoided shutting its doors, claimed Lampert, who is also CEO of Sears Holdings Corp. Source
  • Unifor head Jerry Dias 'glad to be in the middle of it' on NAFTA talks

    Economic CTV News
    OTTAWA - Just hours before Bombardier Inc. was to unveil a dramatic plan to escape its latest crisis, Jerry Dias was summoned to Montreal to meet with Alain Bellemare, the beleaguered firm's chief executive. There, the head of Canada's largest private-sector union was told that after months of searching for partners to help finance its sleek new C Series jet, Bombardier would be teaming up with European manufacturer Airbus, which would take on much of the responsibility for building and selling…
  • Retails jobs at risk from self-service technology, experts say

    Economic CTV News
    VANCOUVER - Retailers are racing to adopt new technologies, like the self-scanner Walmart has rolled out in 22 Canadian stores, to stay competitive in a challenging industry. But experts say the trend toward automation threatens more jobs in a sector that is already slashing head counts. Source
  • Asian stock markets rise after Wall Street loss

    Economic CTV News
    BEIJING - Asian stock markets edged up Tuesday after Wall Street slid overnight as investors sought new drivers for trading activity. KEEPING SCORE: Tokyo's Nikkei 225 rose 0.2 per cent to 21,733.10 points and Sydney's S&P-ASX 200 gained 0.1 per cent to 5,901.10. Source
  • Quebec-based Avior inks multi-year contract with Boeing 737 Max project

    Economic CTV News
    LAVAL, Que. -- Canadian aerospace manufacturer Avior Integrated Products says it has entered into a multi-year contract with Boeing's 737 Max airplane program. The company is a full-service supplier of lightweight structural assemblies and will be involved with access door assembly on the project by the U.S. Source
  • Liberal government to boost Canada child benefit payments: sources

    Economic CBC News
    The federal government will announce plans to boost payments made to families under the Canada child benefit program on Tuesday, CBC News has learned. Multiple sources, speaking to CBC News and Radio-Canada on the condition of anonymity, said the government will foreshadow the increase in the fall economic update, which will be tabled tomorrow, and provide more details later this week. Source
  • Company that runs B.C. casino accused of illegal activity says it follows rules

    Economic CTV News
    RICHMOND, B.C. -- The head of a company that runs a British Columbia casino alleged to have taken in millions that could be proceeds of crime says procedures to ensure compliance with regulations are strictly followed. Source
  • Stelco looking to raise $200M with IPO

    Economic Toronto Sun
    Stelco Holdings Inc. is looking to raise $200 million in its initial public offering, according to documents filed with securities regulators. The steelmaker is expecting to price its shares between $16 and $18 per share. If an over-allotment option is exercised in full, the offering will increase to $230 million. Source
  • Man with allergy dies from walnut shells used at construction site

    Economic CTV News
    EDMONTON -- The family of an Edmonton man with a nut allergy says he died after visiting a work site where walnut shells were used to blast paint off walls. Justin Mathews, who was 33, went into anaphylactic shock at the city's Rossdale fire station on Oct. Source
  • Marijuana company Aphria met with TSX about guidance regarding U.S. business

    Economic CBC News
    Marijuana producer Aphria Inc. says it met with the Toronto Stock Exchange last week to discuss the exchange's recent guidance that pot firms with U.S. exposure could face delisting. Aphria chief executive Vic Neufeld says the company reiterated its commitment to work collaboratively with the TSX as it continues to monitor developments in this sector. Source